Rhizoxin

N/A

Report date: 2026/03/06 20:02:51
NME

Base Information

Drug NameRhizoxin
Drug Alias Name根霉素E-87-010WF-1360E-87/010CRC-87/01 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin polymerisation inhibitorsMitosis inhibitors
TargetsTubulin
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungHead and Neck NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Cancer InstituteAstellas Pharma Inc
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell LungHead and Neck NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksWikipedia